Functional brain connectivity phenotypes for schizophrenia drug discovery.

Area of Science:

• Neuroscience
• Psychiatry
• Pharmacology

Background:

• Despite advances in understanding schizophrenia pathophysiology, effective drug development remains limited.
• Human brain imaging and electrophysiology reveal significant alterations in functional brain networks and neural connectivity in schizophrenia patients.

Purpose of the Study:

• To review findings on altered functional brain connectivity in preclinical rodent models of schizophrenia.
• To assess the translational relevance of these rodent models to human schizophrenia.
• To explore the utility of functional brain connectivity phenotypes in preclinical drug discovery for schizophrenia.

Main Methods:

• Review of recent studies on functional brain connectivity in rodent models relevant to schizophrenia.
• Comparison of findings in rodent models with human neuroimaging and electrophysiological data.
• Analysis of the potential of functional connectivity as a biomarker in drug discovery.

Main Results:

• Preclinical rodent models exhibit altered functional brain connectivity patterns.
• These patterns show relevance and parallels to those observed in human schizophrenia patients.
• Functional connectivity approaches are emerging as valuable tools in preclinical research.

Conclusions:

• Altered functional brain connectivity in rodent models offers a translational bridge to understanding schizophrenia.
• Utilizing functional connectivity phenotypes in preclinical studies can aid in elucidating disease mechanisms.
• This paradigm holds promise for improving the success rate of novel drug discovery for schizophrenia.